BDBM161873 US9682976, 301

SMILES CC1(C)CC[C@H]2C[C@H](CCN12)Nc1nc(Nc2cc(c(cc2F)C2CC2)-n2nnnc2C2COC2)ncc1F

InChI Key InChIKey=GQKJYLNNJNAJFZ-ROUUACIJSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 161873   

TargetInterleukin-2(Homo sapiens (Human))
Rigel Pharmaceuticals

US Patent
LigandPNGBDBM161873(US9682976, 301)
Affinity DataEC50: <100nMAssay Description:Primary T cell stimulation and IL2 ELISA: Human primary T cells (100,000 cells per well) were pre-incubated with or without test compound in Yssel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent